Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bad Times Continue To Hit Merck's Animal Health Segment
Seeking Alpha
Tuesday, July 22, 2014 - 8:43am
tags:
Zilmax, Merck Animal Health, animal health, Merck, Zoetis, Pfizer, Eli Lilly
Johnson & Johnson sets $5 billion share buyback
Marketwatch
Tuesday, July 22, 2014 - 8:37am
tags:
JNJ, share repurchase
Abbvie’s $8 billion in tax breaks from Shire deal may come just in time
Marketwatch
Tuesday, July 22, 2014 - 8:36am
tags:
AbbVie, Shire, tax inversions, M&A, Humira
How Much Will Those Allergan Cost Cuts Really Help? Read Here
WSJ Online
Monday, July 21, 2014 - 3:42pm
tags:
Allergan, restructuring, M&A, Valeant Pharmaceuticals
Sequenom VisibiliT launch unlikely to have near-term impact, says Ladenburg
Yahoo/Fly on the Wall
Monday, July 21, 2014 - 3:41pm
tags:
Sequenom, VisibiliT, diagnostics
Amgen's AMG 416 Succeeds in Phase III, Shares Up
Yahoo/Zacks.com
Monday, July 21, 2014 - 3:38pm
tags:
Amgen, AMG 416, kidney disease
ABBV, MRK And PFE, Pushing Health Care Sector Downward
TheStreet.com
Monday, July 21, 2014 - 3:34pm
tags:
AbbVie, Merck, Pfizer
Gilead Sciences: Sovaldi’s a Blockbuster, the Question is How Big
Barron's
Monday, July 21, 2014 - 11:01am
tags:
Gilead Sciences, Sovaldi, hepatitis C
Monday’s Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Motley Fool
Monday, July 21, 2014 - 10:43am
tags:
Allergan, layoffs, Anacor, Sinovac Biotech, Kerydin, earnings, China, Sandoz, vaccines
Swiss hearing loss firm Auris Medical to raise up to $95 million in US IPO
Reuters
Monday, July 21, 2014 - 10:39am
tags:
IPOs, Auris Medical, hearing loss
Allergan says second-quarter profit rose, announces cost cuts
Reuters
Monday, July 21, 2014 - 10:38am
tags:
Allergan, restructuring, earnings
3 Biotech Stocks Breaking Out on Big Volume
TheStreet.com
Monday, July 21, 2014 - 10:36am
tags:
Ultragenyx, Bluebird Bio, Immunogen
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers
WSJ Online
Monday, July 21, 2014 - 10:35am
tags:
patents, hepatitis C, Gilead Sciences, Merck, AbbVie, Roche
5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise
Seeking Alpha
Monday, July 21, 2014 - 10:19am
tags:
MannKind, Afrezza, diabetes, AstraZeneca, GSK, Eli Lilly, Novo Nordisk, Merck
CVS officials say Sovaldi pricing in line with history, but unsustainable
Marketwatch
Monday, July 21, 2014 - 10:15am
tags:
CVS, Sovaldi, Gilead Sciences, hepatitis C
Valeant accuses Allergan of making misleading statements
Marketwatch
Monday, July 21, 2014 - 9:24am
tags:
Valeant Pharmaceuticals, M&A, Allergan
Allergan to Cut About 1,500 Jobs in Restructuring
Bloomberg
Monday, July 21, 2014 - 9:22am
tags:
Allergan, Valeant Pharmaceuticals, M&A, restructuring, layoffs
Top Biotech Earnings Previews for the Week Ahead
24/7 Wall St
Monday, July 21, 2014 - 9:20am
tags:
earnings, Cubist Pharma, Gilead Sciences, Biogen Idec, Celgene, Illumina, Alexion
Why Abbott's Stake In Mylan Will Be Value-Creative
Seeking Alpha
Monday, July 21, 2014 - 9:17am
tags:
Abbott Labs, Mylan
Alzheimer's Needs Cures, Not Pyrrhic Victories
Motley Fool
Monday, July 21, 2014 - 9:17am
tags:
Alzheimer's disease, pimavanserin, Acadia, Sangamo BioSciences, Valeant Pharmaceuticals, Bexarotene, Merck, BACE inhibitors, AstraZeneca, solanezumab, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.